Deficiency of iNOS-derived NO accelerates lipid accumulation-independent liver fibrosis in non-alcoholic steatohepatitis mouse model

BMC Gastroenterol. 2015 Apr 1:15:42. doi: 10.1186/s12876-015-0269-3.

Abstract

Background: Although many of the factors and molecules closely associated with non-alcoholic steatohepatitis (NASH) have been reported, the role of inducible nitric oxide synthase (iNOS)-derived nitric oxide (NO) on the progression of NASH remains unclear. We therefore investigated the role of iNOS-derived NO in NASH pathogenesis with a long-term follow-up study using systemic iNOS-knockout mice under high-fat diet (HFD) conditions.

Methods: iNOS-knockout and wild-type mice were fed a basal or HFD for 10 or 48 weeks. Lipid accumulation, fibrosis, and inflammation were evaluated, and various factors and molecules closely associated with NASH were analyzed.

Results: Marked fibrosis and inflammation (indicators of NASH) were observed in the livers of iNOS-knockout mice compared to wild-type mice after 48 weeks of a HFD; however, lipid accumulation in iNOS-knockout mice livers was less than in the wild-type. Increased expressions of various cytokines that are transcriptionally controlled by NF-kB in iNOS-deficient mice livers were observed during HFD conditions.

Conclusions: iNOS-derived NO may play a protective role against the progression to NASH during an HFD by preventing fibrosis and inflammation, which are mediated by NF-kB activation in Kupffer cells. A lack of iNOS-derived NO accelerates progression to NASH without excessive lipid accumulation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Basic Helix-Loop-Helix Leucine Zipper Transcription Factors
  • Carrier Proteins / genetics
  • Collagen Type I / genetics
  • Cytokines / genetics
  • Diacylglycerol O-Acyltransferase / genetics
  • Diet, High-Fat
  • Electrophoretic Mobility Shift Assay
  • Fatty Acids, Nonesterified / analysis
  • Follow-Up Studies
  • Gene Expression
  • Insulin Resistance
  • Lipid Metabolism
  • Liver / chemistry*
  • Liver / pathology
  • Liver Cirrhosis / etiology
  • Liver Cirrhosis / metabolism*
  • Liver Cirrhosis / pathology
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Nitric Oxide / analysis
  • Nitric Oxide / deficiency
  • Nitric Oxide / metabolism*
  • Nitric Oxide Synthase Type II / genetics
  • Nitric Oxide Synthase Type II / metabolism*
  • Non-alcoholic Fatty Liver Disease / complications
  • Non-alcoholic Fatty Liver Disease / metabolism*
  • Non-alcoholic Fatty Liver Disease / pathology
  • Nuclear Proteins / genetics
  • PPAR alpha / genetics
  • Platelet-Derived Growth Factor / genetics
  • RNA, Messenger / analysis*
  • Sterol Regulatory Element Binding Protein 1 / genetics
  • Time Factors
  • Tissue Inhibitor of Metalloproteinase-1 / genetics
  • Tissue Inhibitor of Metalloproteinase-2 / genetics
  • Transcription Factors / genetics
  • Triglycerides / analysis

Substances

  • Basic Helix-Loop-Helix Leucine Zipper Transcription Factors
  • Carrier Proteins
  • Collagen Type I
  • Cytokines
  • Fatty Acids, Nonesterified
  • Mlxipl protein, mouse
  • Nuclear Proteins
  • PPAR alpha
  • Platelet-Derived Growth Factor
  • RNA, Messenger
  • Srebf1 protein, mouse
  • Sterol Regulatory Element Binding Protein 1
  • Timp1 protein, mouse
  • Tissue Inhibitor of Metalloproteinase-1
  • Transcription Factors
  • Triglycerides
  • microsomal triglyceride transfer protein
  • Tissue Inhibitor of Metalloproteinase-2
  • Nitric Oxide
  • Nitric Oxide Synthase Type II
  • DGAT2 protein, mouse
  • Diacylglycerol O-Acyltransferase